Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

16.56
-1.3800-7.69%
Post-market: 16.560.00000.00%19:40 EDT
Volume:3.23M
Turnover:54.05M
Market Cap:1.47B
PE:-4.06
High:17.26
Open:16.65
Low:15.99
Close:17.94
Loading ...
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities